ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $716 | -18.5% | 20,074 | +5.4% | 0.01% | -16.7% |
| Q2 2023 | $879 | +6.8% | 19,049 | -7.2% | 0.01% | 0.0% |
| Q1 2023 | $823 | -12.0% | 20,516 | +1.7% | 0.01% | -14.3% |
| Q4 2022 | $935 | -99.9% | 20,175 | -7.6% | 0.01% | 0.0% |
| Q3 2022 | $904,000 | +47.0% | 21,827 | +111.6% | 0.01% | +75.0% |
| Q2 2022 | $615,000 | -36.6% | 10,313 | -22.8% | 0.00% | -20.0% |
| Q1 2022 | $970,000 | -7.0% | 13,357 | +7.7% | 0.01% | 0.0% |
| Q4 2021 | $1,043,000 | +14.2% | 12,399 | +22.4% | 0.01% | 0.0% |
| Q3 2021 | $913,000 | +19.0% | 10,127 | +25.9% | 0.01% | +25.0% |
| Q2 2021 | $767,000 | -1.2% | 8,043 | +18.1% | 0.00% | 0.0% |
| Q1 2021 | $776,000 | +9.1% | 6,813 | +32.7% | 0.00% | 0.0% |
| Q4 2020 | $711,000 | +171.4% | 5,134 | +61.0% | 0.00% | +100.0% |
| Q3 2020 | $262,000 | -38.4% | 3,189 | -42.7% | 0.00% | -33.3% |
| Q3 2018 | $425,000 | -42.2% | 5,570 | -41.7% | 0.00% | -40.0% |
| Q2 2018 | $735,000 | +45.8% | 9,561 | -3.2% | 0.01% | +66.7% |
| Q1 2018 | $504,000 | -20.0% | 9,875 | -27.3% | 0.00% | -25.0% |
| Q4 2017 | $630,000 | +208.8% | 13,578 | +351.1% | 0.00% | +300.0% |
| Q1 2017 | $204,000 | -3.8% | 3,010 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $212,000 | -25.4% | 3,010 | -24.9% | 0.00% | 0.0% |
| Q3 2016 | $284,000 | +14.1% | 4,010 | -21.1% | 0.00% | 0.0% |
| Q2 2016 | $249,000 | +18.0% | 5,085 | +52.6% | 0.00% | +100.0% |
| Q1 2016 | $211,000 | -26.0% | 3,333 | +31.3% | 0.00% | -50.0% |
| Q4 2015 | $285,000 | -9.8% | 2,538 | -22.6% | 0.00% | 0.0% |
| Q3 2015 | $316,000 | +247.3% | 3,281 | +271.2% | 0.00% | +100.0% |
| Q2 2015 | $91,000 | +111.6% | 884 | +28.5% | 0.00% | – |
| Q1 2015 | $43,000 | +72.0% | 688 | +19.4% | 0.00% | – |
| Q4 2014 | $25,000 | +66.7% | 576 | +114.9% | 0.00% | – |
| Q3 2014 | $15,000 | +25.0% | 268 | +2.7% | 0.00% | – |
| Q2 2014 | $12,000 | – | 261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |